Jan 21, 2026 | Arbitration, Blog Post, Private Equity
It’s no surprise that private equity-backed providers—including Nutex Health—have co-opted the No Surprises Act’s (NSA) IDR process into their go-to profit center. It’s the reason why private equity-backed championed arbitration as their “solution” to the surprise...
Jan 13, 2026 | Arbitration, Blog Post, Private Equity
Congress and the President enacted the No Surprises Act to protect patients from outrageous medical bills and create a balanced, predictable system for resolving payment disputes between health plans and providers, while lowering costs. Instead, some private...
Nov 17, 2025 | Blog Post, Private Equity
When Congress passed the No Surprises Act, the goal was clear: protect patients from unexpected out-of-network medical bills and lower costs for employees and employers. But a new analysis from the Private Equity Stakeholder Project (PESP) finds that private equity is...
Sep 30, 2025 | Arbitration, Blog Post, Private Equity
The rise of the “IDR middlemen” is one of the clearest examples of how the arbitration process under the No Surprises Act is wrapping the health care system in red tape and increasing costs for patients and employers. A recent BusinessMole article highlights how...
Sep 16, 2025 | Arbitration, Blog Post, Private Equity
The No Surprises Act represented a landmark achievement—one designed to protect patients from unexpected medical bills. But while the law’s intent was clear, its implementation—particularly the arbitration process, also known as the independent dispute resolution...
Sep 2, 2025 | Arbitration, Blog Post, Private Equity
A new Health Affairs article from Georgetown University’s Center on Health Insurance Reforms reveals how the Independent Dispute Resolution (IDR) process under the No Surprises Act has veered sharply off course, driving $5 billion in wasteful health care spending that...
Recent Comments